These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21145100)

  • 61. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer.
    Murad AM; Triginelli SA; Ribalta JC
    J Clin Oncol; 1994 Jan; 12(1):55-9. PubMed ID: 7505808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer.
    Zanetta G; Fei F; Parma G; Balestrino M; Lissoni A; Gabriele A; Mangioni C
    Ann Oncol; 1999 Oct; 10(10):1171-4. PubMed ID: 10586332
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer.
    Song D; Kong W; Zhang T; Han C; Liu T; Jiao S; Chen J
    J Obstet Gynaecol; 2019 Apr; 39(3):389-394. PubMed ID: 30663464
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in "real world" patients.
    Godoy-Ortiz A; Plata Y; Alcaide J; Galeote A; Pajares B; Saez E; Alba E; Sánchez-Muñoz A
    Clin Transl Oncol; 2018 Jul; 20(7):922-927. PubMed ID: 29222647
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer.
    Takekida S; Fujiwara K; Nagao S; Yamaguchi S; Yoshida N; Kitada F; Kigawa J; Terakawa N; Nishimura R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1563-8. PubMed ID: 21370599
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme.
    Aoki T; Mizutani T; Nojima K; Takagi T; Okumura R; Yuba Y; Ueba T; Takahashi JA; Miyatake S; Nozaki K; Taki W; Matsutani M
    J Neurosurg; 2010 Jan; 112(1):50-6. PubMed ID: 19538050
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
    Lissoni AA; Colombo N; Pellegrino A; Parma G; Zola P; Katsaros D; Chiari S; Buda A; Landoni F; Peiretti M; Dell'anna T; Fruscio R; Signorelli M; Grassi R; Floriani I; Fossati R; Torri V; Rulli E
    Ann Oncol; 2009 Apr; 20(4):660-5. PubMed ID: 19181826
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer.
    Secord AA; Havrilesky LJ; Carney ME; Soper JT; Clarke-Pearson DL; Rodriguez GC; Berchuck A
    Int J Clin Oncol; 2007 Feb; 12(1):31-6. PubMed ID: 17380438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1.
    Nishio S; Kitagawa R; Shibata T; Yoshikawa H; Konishi I; Ushijima K; Kamura T
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):785-90. PubMed ID: 27553435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
    Verschraegen CF; Kavanagh JJ; Loyer E; Bodurka-Bevers D; Kudelka AP; Hu W; Vincent M; Nelson T; Levenback C;
    Cancer; 2001 Nov; 92(9):2327-33. PubMed ID: 11745287
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Paclitaxel-ifosfamide-carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours.
    Kosmas C; Vorgias G; Tsakonas G; Politis P; Daladimos T; Panagiotidi E; Papachrysanthou T; Moschovis D; Kalinoglou N; Tsavaris N; Karabelis A; Mylonakis N
    Br J Cancer; 2011 Sep; 105(7):897-902. PubMed ID: 21847127
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature.
    Termrungruanglert W; Kudelka AP; Piamsomboon S; Edwards CL; Verschraegen CF; Loyer E; Kavanagh JJ
    Eur J Gynaecol Oncol; 1996; 17(6):493-6. PubMed ID: 8971525
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Mountzios G; Dimopoulos MA; Bamias A; Vourli G; Kalofonos H; Aravantinos G; Fountzilas G; Papadimitriou CA
    Ann Oncol; 2009 Aug; 20(8):1362-8. PubMed ID: 19457937
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Reversible posterior leukoencephalopathy post-chemotherapy with carboplatin and paclitaxel].
    Jamelot M; Fontanilles M; Vaschalde Y
    Bull Cancer; 2019 Dec; 106(12):1191-1195. PubMed ID: 31472945
    [No Abstract]   [Full Text] [Related]  

  • 76. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
    Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
    Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
    Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
    Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.
    Li Y; Zeng J; Huang M; An J; Bai P; Wu L; Zhang R
    Cancer; 2017 Feb; 123(3):420-425. PubMed ID: 27696395
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
    Redondo A; Colombo N; McCormack M; Dreosti L; Nogueira-Rodrigues A; Scambia G; Lorusso D; Joly F; Schenker M; Ruff P; Estevez-Diz M; Irahara N; Donica M; Gonzalez-Martín A
    Gynecol Oncol; 2020 Oct; 159(1):142-149. PubMed ID: 32763109
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    Karageorgopoulou S; Kostakis ID; Gazouli M; Markaki S; Papadimitriou M; Bournakis E; Dimopoulos MA; Papadimitriou CA
    BMC Cancer; 2017 Jun; 17(1):451. PubMed ID: 28659181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.